Molecular Structure and Function of Janus Kinases: Implications for the Development of Inhibitors. [PDF]
Garrido-Trigo A, Salas A.
europepmc +1 more source
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. [PDF]
ObjectiveTofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). The pathways affected by tofacitinib and the effects on gene expression in situ are unknown.
Boyle, DL +14 more
core
Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
Chang Y +26 more
europepmc +1 more source
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. [PDF]
Bharadwaj U +3 more
europepmc +1 more source
STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ducts. [PDF]
Dennaoui R +10 more
europepmc +1 more source
Pharmacological inhibition of the Janus Kinases enhances ASCL1 protein stability and transcriptional activity. [PDF]
Hanspal MA +4 more
europepmc +1 more source
Effect of 6,7-dimethoxy-2,2-dimethyl-2H-chromene (agerarin) on the recovery of filaggrin expression through targeting of Janus kinases in the inflammatory skin. [PDF]
Ahn SS +6 more
europepmc +1 more source
Epigenomic landscapes define differential Janus kinases inhibitor sensitivity in IFN-γ-primed human macrophages. [PDF]
Kwon G +4 more
europepmc +1 more source
FDA-approved small-molecule kinase inhibitors [PDF]
Clausen, Mads Hartvig +2 more
core +1 more source

